Adial Pharmaceuticals Inc is a biopharmaceutical company focused on developing innovative therapies for the treatment of addiction and related disorders

The company is primarily engaged in the research and clinical development of its lead product candidate, which aims to reduce the risk of relapse in patients with alcohol use disorder. Adial utilizes a patient population-centric approach to address significant unmet medical needs in substance use disorders through its proprietary technology and scientific expertise. By leveraging partnerships and conducting clinical trials, Adial is committed to advancing solutions that improve the lives of individuals affected by addiction.